ImmunoGen Announces Conference Call to Discuss Its First Quarter 2022 Operating Results
ImmunoGen Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that the Company will host a conference call at 8:00 a.m. ET on Friday, May 6, 2022 to discuss its first quarter 2022 operating results. Management will also provide a brief update on the business.
CONFERENCE CALL INFORMATION
To access the live call by phone, dial (877) 621-5803; the conference ID is 5444669. The call may also be accessed through the Investors and Media section of the Company's website, www.immunogen.com. Following the call, a replay will be available at the same location.
ABOUT IMMUNOGEN
ImmunoGen is developing the next generation of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. By generating targeted therapies with enhanced anti-tumor activity and favorable tolerability profiles, we aim to disrupt the progression of cancer and offer our patients more good days. We call this our commitment to TARGET A BETTER NOWtm.
Learn more about who we are, what we do, and how we do it at www.immunogen.com.
Evolution Equity Partners announced the final closing of Evolution Technology Fund III, LP on April 16th, 2024, and total capital commitments of $ 1.1 Billion to back visionary entrepreneurs building next generation...
SessionGuardian, a leading provider of continuous identity assurance and data protection solutions, celebrates the addition of its newly appointed, exceptional advisors. The remarkable achievements and insights of these key industry leaders will...
Arizona Governor Katie Hobbs, Arizona Corporation Commission (ACC) Commissioner Lea Marquez Peterson, and executives from Arizona Public Service (APS), Longroad Energy (Longroad), McCarthy Building Companies (McCarthy), and U.S. Bancorp Impact...
Terra Drone Corporation, a leading drone and Advanced Air Mobility (AAM) technology provider headquartered in Japan, announced today the launch of joint development with its Group companies Unifly NV ("Unifly") and Aloft Technologies Inc. ("Aloft")...
Terra Drone Corporation, a leading drone and Advanced Air Mobility (AAM) technology provider headquartered in Japan, has announced the launch of joint development with its Group companies Unifly NV ("Unifly") and Aloft Technologies Inc. ("Aloft")...
